/ Published in 2014, Publication

Impact of malaria and helminth infections on immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in Tanzania.

Impact of malaria and helminth infections on immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in Tanzania.

Brown J, Baisley K, Kavishe B, Changalucha J, Andreasen A, Mayaud P, Gumodoka B, Kapiga S, Hayes R, Watson-Jones D.

Vaccine 2014;32:611-7.

PMID:24291193

PMCID:PMC3898269

DOI:10.1016/j.vaccine.2013.11.061

Related citation

What you can read next

Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: simulation results.
Difference in blood pressure response to ACE-Inhibitor monotherapy between black and white adults with arterial hypertension
HPV infection and increased risk of HIV acquisition. A systematic review and meta-analysis.